Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

TSX:RVX - Post Discussion

View:
Post by ENEMENEMYNEMO on Dec 21, 2020 5:23pm

COVID

Maybe some news on their COVID studies. An email to the company last week confirmed recent collaborations but no specifics.
Comment by G1945V on Dec 21, 2020 6:56pm
Nemo, you mind sharing what ever information you received from the company. TIA G1945V
Comment by ENEMENEMYNEMO on Dec 21, 2020 8:20pm
"""Thank you for your interest in apabetalone and COVID-19. Please see news on COVID here:https://www.resverlogix.com/investors/news?article=682   Article: https://www.sciencedirect.com/science/article/pii/S2590098620300567?via%3Dihub   AHA presentation:  https://www.resverlogix.com/upload/media_element/228/4c0d88964de2/aha-2020-covid-19_eposter.final.dg.lf.pdf & ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities